会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明公开
    • METHOD OF STERILIZING PREFILLED SYRINGE MEDICINES
    • VERFAHREN ZUR STERILISIERUNG VON MEDIKAMENTEN INVORGEFÜLLTENSPRITZEN
    • EP0739638A1
    • 1996-10-30
    • EP95928621.2
    • 1995-08-21
    • EIKEN CHEMICAL CO., LTD.
    • MATSUMOTO, YasuyukiSAITO, MasahiroMORIKAWA, JunjiTAKANO, Hiroshi
    • A61M5/31A61L2/06
    • A61L2/06A61L2/26A61M5/001
    • The invention provides a method of sterilizing a chemical and an injector in a prefilled syringe and keeping them in sterilized condition, said method comprising mounting a liquid leakage preventive cap (1) on a tip end of an injector (2) in a prefilled syringe, filled with a chemical and mounting a sliding plug (3) in an opening at a rear end of the injector to prevent liquid leakage of the prefilled syringe, securing the prefilled syringe, which mounts thereto the liquid leakage preventive cap (1) and the sliding plug (3), by means of a securing container (6), sealing the securing container (6), to which the prefilled syringe (2) is fixed, by means of a poromeric and bacteria impermeable nonwoven paper or fabric to sterilize a chemical (5) in the prefilled syringe (2), the prefilled syringe (2) and the securing container at the same time. The securing container (6) is enclosed by a bag-shaped nonwoven paper or fabric (7). Alternatively, the securing container (6) may have an opening, and the opening may be sealed by the nonwoven paper or fabric (11). According to the invention, it is possible to manufacture a prefilled syringe kit readily at low cost in a sterilized manner and keep the sterilized condition.
    • 本发明提供了一种在预充式注射器中对化学药剂和注射器进行灭菌并将其保持在灭菌状态的方法,所述方法包括将防漏液帽(1)安装在预充式注射器中的注射器(2)的末端上, 填充有化学品并将滑动塞(3)安装在喷射器后端的开口中,以防止预填充的注射器的液体泄漏,固定预充式注射器,该注射器安装在防漏液盖(1)上并滑动 通过固定容器(6)将塞子(3),借助于通孔和细菌不可渗透的非织造纸或织物将固定的预充式注射器(2)固定到其上的固定容器(6)进行灭菌 (5)在预充式注射器(2)中,预充式注射器(2)和固定容器同时进行。 固定容器(6)由袋状非织造纸或织物(7)包围。 或者,固定容器(6)可以具有开口,并且开口可以被非织造纸或织物(11)密封。 根据本发明,可以以无菌方式以低成本容易地制造预填充注射器套件并保持灭菌状态。
    • 15. 发明公开
    • Assay for detecting nucleic acid sequence
    • 用于检测核酸序列的测定
    • EP0639647A2
    • 1995-02-22
    • EP94110526.4
    • 1994-07-06
    • TANABE SEIYAKU CO., LTD.EIKEN CHEMICAL Co., Ltd.
    • Yamagata, KoichiUmemura, IsaoShibatani, Takeji
    • C12Q1/68
    • C12Q1/6846C12Q2565/107C12Q2521/101
    • Assay for detecting nucleic acid sequence, which comprises the steps: [A] contacting (1) a target single-stranded nucleic acid, (2) a pair of nucleic acid primers having nucleotide sequence complementary to the target nucleic acid and its complementary chain respectively, (3) a fluorescent-labeled nucleic acid probe which has a nucleotide sequence designed so as to be hybridized to the target nucleic acid downstream (at the side of 3'-terminus) from where the nucleic acid primer is hybridized and has a modified 3'-end so that the nucleotide chain is not elongated by a nucleic acid polymerase, and (4) a nucleic acid polymerase having exonuclease activity specific to a double-stranded nucleic acid in the presence of substrates for the enzyme (four kinds of nucleoside triphosphate), and thereby elongating the said nucleic acid primer chain and simultaneously hydrolyzing only the fluorescent-labeled nucleic acid probe hybridized to the target nucleic acid; [B] denaturating the chain-elongated product of primer to a single-stranded form; [C] amplifying the target nucleic acid by repeating the steps A and B; and [D] determining the change in fluorescence polarization resulted by the hydrolysis of the probe. This method is effective to detect the target nucleic acid sequence more simply with higher sensitivity and higher reliability in comparison with known methods, and further has advantages that because of no carryover or contamination of the amplified nucleic acids into subsequent reactions, undesirable false positive result can be avoided.
    • (A)接触(1)目标单链核酸,(2)具有分别与目标核酸及其互补链互补的核苷酸序列的核酸引物对,所述核酸序列分析包括以下步骤:[A] ,(3)荧光标记的核酸探针,其具有被设计成与靶核酸杂交的核酸序列,所述靶核酸与核酸引物杂交的下游(3'末端侧)并具有修饰 3'末端,以便核酸聚合酶不延长核苷酸链,和(4)在酶的底物存在下具有对双链核酸特异的外切核酸酶活性的核酸聚合酶(四种核苷 由此延长所述核酸引物链,并且同时仅水解与靶核酸杂交的荧光标记的核酸探针; [B]将引物的伸长链产物变性为单链形式; [C]通过重复步骤A和B扩增靶核酸; 和[D]确定由探针水解引起的荧光偏振的变化。 与已知方法相比,该方法更有效地检测目标核酸序列,具有更高的灵敏度和更高的可靠性,并且还具有以下优点:由于扩增的核酸没有携带或污染到后续反应中,所以不希望的假阳性结果可以 应避免。
    • 17. 发明公开
    • Assay for detecting nucleic acid sequence
    • 一种用于检测核酸序列的方法。
    • EP0639647A3
    • 1995-07-12
    • EP94110526.4
    • 1994-07-06
    • TANABE SEIYAKU CO., LTD.EIKEN CHEMICAL Co., Ltd.
    • Yamagata, KoichiUmemura, IsaoShibatani, Takeji
    • C12Q1/68
    • C12Q1/6846C12Q2565/107C12Q2521/101
    • Assay for detecting nucleic acid sequence, which comprises the steps: [A] contacting (1) a target single-stranded nucleic acid, (2) a pair of nucleic acid primers having nucleotide sequence complementary to the target nucleic acid and its complementary chain respectively, (3) a fluorescent-labeled nucleic acid probe which has a nucleotide sequence designed so as to be hybridized to the target nucleic acid downstream (at the side of 3'-terminus) from where the nucleic acid primer is hybridized and has a modified 3'-end so that the nucleotide chain is not elongated by a nucleic acid polymerase, and (4) a nucleic acid polymerase having exonuclease activity specific to a double-stranded nucleic acid in the presence of substrates for the enzyme (four kinds of nucleoside triphosphate), and thereby elongating the said nucleic acid primer chain and simultaneously hydrolyzing only the fluorescent-labeled nucleic acid probe hybridized to the target nucleic acid; [B] denaturating the chain-elongated product of primer to a single-stranded form; [C] amplifying the target nucleic acid by repeating the steps A and B; and [D] determining the change in fluorescence polarization resulted by the hydrolysis of the probe. This method is effective to detect the target nucleic acid sequence more simply with higher sensitivity and higher reliability in comparison with known methods, and further has advantages that because of no carryover or contamination of the amplified nucleic acids into subsequent reactions, undesirable false positive result can be avoided.
    • 18. 发明公开
    • Medium for culturing animal cells or antibody-producing cells
    • 生产培养基用于培养动物细胞或该抗体的细胞。
    • EP0659880A1
    • 1995-06-28
    • EP94309730.3
    • 1994-12-22
    • EIKEN CHEMICAL CO., LTD.
    • Hashimoto, Makoto, c/o EIKEN CHEMICAL CO., LTD.Naito, Tsutomu, c/o EIKEN CHEMICAL CO., LTD.
    • C12N5/00C12P21/00C12P21/08
    • C12N5/163C12N5/0037C12N5/005C12N2500/30C12N2500/32C12N2500/38C12N2500/46C12N2500/90C12N2500/95C12N2501/999Y10S530/808Y10S530/809
    • The present invention relates to a medium for culturing animal cells containing at least one component selected from the group of substances mentioned below; a method for culturing animal cells comprising adding to a medium for the cells as a cell growth promoting substance at least one component selected from the group mentioned below; a method for enhancing the antibody production of antibody-producing cells comprising adding to a medium for the cells at least one component selected from the group mentioned below; a composition for enhancing the antibody production of antibody-producing cells containing at least one antibody production enhancing agent selected from the group mentioned below; and a method for producing a physiologically active substance comprising culturing animal cells on a medium containing at least one cell growth promoting substance selected from the group mentioned below, and then harvesting the cells grown or the substances produced by the cells.
         D-penicillamine or salts thereof
         Acetoacetic acid or salts thereof
         Biguanides
         Vitamin K₅ or salts thereof
         N-acetyl-L-glutamic acid or salts thereof
    • 本发明涉及一种用于培养含有选自以下举出的物质中选择的至少一种成分的动物细胞培养基; 用于培养动物细胞包括向为所述细胞从下面提及的组中选择的至少一种成分的细胞生长促销婷物质的介质的方法; 为了提高抗体产生抗体产生细胞包括向用于从下面提及的组中选择的至少一种组分的细胞的培养基的方法; 为了提高抗体产生含有至少一种抗体的产生增强从下面提及的组中选择的试剂的抗体产生细胞的组合物; 和用于产生生理活性物质包含含有从下面提及的组中选择的至少一种细胞生长促销婷物质的培养基上培养的动物细胞,然后收获生长的细胞或由所述细胞产生的物质的方法。 D-青霉胺或其乙酰乙酸或它们的盐双胍类维生素K5或其盐的N-乙酰基-L-谷氨酸或其盐的盐
    • 19. 发明专利
    • &bgr;−ラクタマーゼ検出方法
    • -LACTAMASE检测方法
    • JP2014200200A
    • 2014-10-27
    • JP2013079267
    • 2013-04-05
    • 栄研化学株式会社Eiken Chemical Co Ltd
    • KAWAI TOMOAKIKAWAGUCHI KOHEIFUJISAKI MOMOKO
    • C12Q1/34C12M1/34C12Q1/02G01N31/22
    • 【課題】短時間に&bgr;−ラクタマーゼの基質特異性に基づく詳細な酵素分類の判定が可能な方法及びそれに用いる試薬を提供することを課題とする。【解決手段】工程(a)及び(b)を含むことを特徴とする微生物の&bgr;−ラクタマーゼ検出方法及び判定方法であって、工程(a)が、第一の薬剤;ペニシリン系、第二の薬剤;第一世代セフェム系、第三の薬剤;第三世代セフェム系及び/または第四世代セフェム系、第四の薬剤;モノバクタム系、第五の薬剤;セファマイシン系及び/またはオキサセフェム系、並びに第六の薬剤;カルバペネム系、からなる6系統の&bgr;−ラクタム薬の各々を検出対象微生物に接触させ、各薬剤の分解の有無をアシドメトリー法により判別する工程であり、工程(b)が、工程(a)における各薬剤の分解有無の判別結果に基づいて検出対象微生物の酵素分類の判定を行う工程である、&bgr;−ラクタマーゼの検出方法及び判定方法。【選択図】なし
    • 要解决的问题:提供一种能够基于β-内酰胺酶的底物特异性以及其试剂在短时间内对酶进行详细分类的方法。解决方案:用于检测和测定微生物的方法 - 内酰胺酶包括以下步骤:(a)使以下六种类别的β-内酰胺与待测试的微生物接触,以通过酸度测定法确定各种药物的分解的存在或不存在,其中六类& β-内酰胺是:1.青霉素,2.第一代头孢烯,3.第三代头孢烯和/或第四代头孢烯,4.单宁,5.头孢霉素和/或oxacephem; 6.碳青霉烯; (b)基于步骤(a)中获得的分解结果确定待测试的目标微生物的酶分类。